Feedback / Questions
namilumab (IZN-101) - Amgen, Izana Biosci, Roivant
http://www.ncbi.nlm.nih.gov/pubmed/40939735
Bernt van den Blink; Chantal M Petit; Hayes M Dansky; Marlies Wijsenbeek-Lourens; Min Lin; Robert P Baughman; Surinder S Birring; Theodore F Reiss
Sep 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next